
Members
Samantha has been working with ctDNA applications for monitoring of treatment response, identifying markers of resistance, and matching drugs to actionable targets.
In this condensed tutorial, Vessel presents three real-world cases of patients with confirmed progressive disease in which liquid biopsy was used to identify actionable targets. The tutorial also includes a brief summary of the patient's history and the results of the liquid biopsy.